KLHL17
Kelch-like protein 17
Also known as: KLH17_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6TDP4
- Gene
- KLHL17
- Ensembl
- ENSG00000187961
- Chromosome
- 1
- Canonical length
- 642 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
The protein encoded by this gene is expressed in neurons of most regions of the brain. It contains an N-terminal BTB domain, which mediates dimerization of the protein, and a C-terminal Kelch domain, which mediates binding to F-actin. This protein may play a key role in the regulation of actin-based neuronal function. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
642 residues, UniProt reviewed canonical sequence.
>Q6TDP4|KLHL17
1 MQPRSERPAG RTQSPEHGSP GPGPEAPPPP PPQPPAPEAE RTRPRQARPA APMEGAVQLL
61 SREGHSVAHN SKRHYHDAFV AMSRMRQRGL LCDIVLHVAA KEIRAHKVVL ASCSPYFHAM
121 FTNEMSESRQ THVTLHDIDP QALDQLVQFA YTAEIVVGEG NVQTLLPAAS LLQLNGVRDA
181 CCKFLLSQLD PSNCLGIRGF ADAHSCSDLL KAAHRYVLQH FVDVAKTEEF MLLPLKQVLE
241 LVSSDSLNVP SEEEVYRAVL SWVKHDVDAR RQHVPRLMKC VRLPLLSRDF LLGHVDAESL
301 VRHHPDCKDL LIEALKFHLL PEQRGVLGTS RTRPRRCEGA GPVLFAVGGG SLFAIHGDCE
361 AYDTRTDRWH VVASMSTRRA RVGVAAVGNR LYAVGGYDGT SDLATVESYD PVTNTWQPEV
421 SMGTRRSCLG VAALHGLLYS AGGYDGASCL NSAERYDPLT GTWTSVAAMS TRRRYVRVAT
481 LDGNLYAVGG YDSSSHLATV EKYEPQVNVW SPVASMLSRR SSAGVAVLEG ALYVAGGNDG
541 TSCLNSVERY SPKAGAWESV APMNIRRSTH DLVAMDGWLY AVGGNDGSSS LNSIEKYNPR
601 TNKWVAASCM FTRRSSVGVA VLELLNFPPP SSPTLSVSST SLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLHL17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 12 nTPM
- testis: 10 nTPM
- esophagus: 9.3 nTPM
- spleen: 8.9 nTPM
- pituitary gland: 8 nTPM
- kidney: 7.5 nTPM
Single-cell type
- oocytes: 9.2 nCPM
- undifferentiated spermatogonia: 8.1 nCPM
- esophageal apical cells: 6.7 nCPM
- retinal amacrine cells: 6.3 nCPM
- astrocytes: 5.6 nCPM
- differentiating spermatogonia: 5.5 nCPM
Immune cell
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 9.6 nTPM
- cerebellum: 6.8 nTPM
- medulla oblongata: 6.1 nTPM
- thalamus: 6.1 nTPM
- pons: 6 nTPM
- hippocampal formation: 5.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KLHL17.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 221 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.57
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein ubiquitination
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KLHL17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLHL17 as an antibody target. Whether an autoantibody or antibody against KLHL17 could matter depends on whether native KLHL17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLHL17 is annotated as secreted, so native KLHL17 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label KLHL17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...